Aequitron Medical acquires central nervous systems (CNS) sleep diagnostic range:
This article was originally published in Clinica
Executive Summary
Electronic respiratory product manufacturer Aequitron Medical is to acquire CNS' sleep diagnostic business which has annual revenues of $7 million. The combined $6 million cash and debt transaction gives Aequitron rights to all CNS' sleep disorder diagnostic products as well as a product in development. It also gains distribution rights to CNS' Breathe Right nasal strips to professional healthcare markets. Production and staffing for the CNS products will move to Aequitron Medical's headquarters in Plymouth, Minnesota. CNS chairman and CEO Daniel Cohen says the company intends to concentrate on developing its core business - the Breathe Right product line.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.